MediPharm Labs, Corp. (TSX: LABS) is launching a sublingual spray, available for patients through an online medical cannabis platform run by pharmacy chain Shopper’s Drug Mart.
The new product format is part of MediPharm’s three-year manufacturing agreement with bio-pharmaceutical company Avicanna, Inc. (TSX: AVCN), signed May 14, 2020.
The product will be marketed under Avicanna’s “Rho Phyto” medical brand and will be available to patients in the coming weeks.
Read more: MediPharm completes first topicals shipment
Sublingual sprays are a way to use cannabis that is not inhaled or ingested. The spray goes under the tongue or on the inside of the cheek and is then absorbed into the body’s bloodstream. The Ontario Cannabis Store says oral sprays can have a similar onset time to edibles and the effects last longer than inhaled cannabis — so as always, the recommendation is to start low and go slow.
In a Wednesday statement, MediPharm said the Rho Phyto sprays absorb into the bloodstream faster than other sublingual sprays on the market. It also noted the “pleasing” taste of the product but did not specify a flavour.
“Medical cannabis users will be delighted with the quality and reliability of RHO Phyto Rapid Act Sprays and more broadly with the fact that Avicanna is leading the way in bringing new and innovative sustainable plant-derived cannabinoid-based products to assist in their care and wellbeing,” MediPharm CEO Pat McCutcheon said in a statement.
Under the agreement MediPharm provides the medical cannabis for Rho Phyto sprays, Rho Phyto drops and for a previously released product, Pura Earth topicals.
“Our Rho Phyto Rapid Act Sprays, which are the second set of products delivered by MediPharm’s technical team within only one month, provide patients and the medical community with an advanced solution for acute relief and an incredible candidate for replacing inhalation products,” Avicanna CEO Aras Azadinan said in the statement.
Top image via Deposit Photos